SUBSEQUENT ANDROGEN DEPRIVATION THERAPY AFTER INITIAL TREATMENT IN INTERMEDIATE RISK PROSTATE CANCER: PROSPECTIVE DATA FROM A PHASE III TRIAL

被引：0
|
作者：
Nabid, Abdenour [1 ]
Carrier, Nathalie [1 ]
Vigneault, Eric [2 ]
Thu Van Nguyen [3 ]
Vavassis, Peter [3 ]
Brassard, Marc-Andre [1 ]
Bahoric, Boris [3 ]
Archambault, Robert [4 ,5 ]
Vincent, Francois [3 ]
Bettahar, Redouane [2 ]
Wilke, Derek [6 ]
Souhami, Luis [3 ]
Nabid, Abdenour [1 ]
机构：
[1] Univ Sherbrooke, Sherbrooke, PQ, Canada
[2] Univ Laval, Quebec City, PQ, Canada
[3] Univ Montreal, Montreal, PQ, Canada
[4] Univ Quebec Outaouais, Gatineau, PQ, Canada
[5] McGill Univ, Gatineau, PQ, Canada
[6] Dalhousie Univ, Halifax, NS, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2019年 / 139卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
24
引用
收藏
页码：S13 / S14
页数：2
相关论文
共 50 条
  • [41] Influence of Age on Treatment Outcomes in Intermediate or High-Risk Prostate Cancer Treated with Androgen Deprivation Therapy and Radiation Therapy
    Bryant, A. K.
    Kader, K.
    Mckay, R.
    Einck, J. P.
    Parsons, J. K.
    Kane, C. J.
    Mundt, A. J., Jr.
    Murphy, J. D.
    Rose, B. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E103 - E103
  • [42] Androgen Deprivation Therapy as Primary Treatment for Prostate Cancer
    Cannata, Dara H.
    Kirschenbaum, Alexander
    Levine, Alice C.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (02): : 360 - 365
  • [43] Causes of death in intermediate- and high-risk prostate cancer treated with radiotherapy with or without androgen deprivation therapy: Analysis from two phase III trials
    Nabid, Abdenour
    Carrier, Nathalie
    Vigneault, Eric
    Martin, Andre-Guy
    Souhami, Luis
    Duclos, Marie
    Bahary, Jean-Paul
    Nguyen-Huynh, Thu-Van
    Lemaire, Celine
    Brassard, Marc-Andre
    Vass, Sylvie
    Bahoric, Boris
    Archambault, Robert
    Vincent, Francois
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [44] Androgen deprivation and cardiovascular risk in prostate cancer treatment
    Leclercq, C.
    Bouchot, O.
    Azzouzi, A. -R.
    Joly, F.
    Miaadi, N.
    Pfister, C.
    Vincendeau, S.
    de Crevoisier, R.
    PROGRES EN UROLOGIE, 2012, 22 : S48 - S54
  • [45] Timing of androgen-deprivation therapy and radical radiotherapy in localized prostate cancer: a phase III randomized controlled trial
    Nieder, Carsten
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (08) : 738 - 739
  • [46] Brachytherapy for Intermediate-Risk Prostate Cancer, Androgen Deprivation, and the Risk of Death
    Pickles, Tom
    Tyldesley, Scott
    Hamm, Jeremy
    Virani, Sean A.
    Morris, W. James
    Keyes, Mira
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (01): : 45 - 52
  • [47] Androgen deprivation therapy and risk of diabetes mellitus in men undergoing androgen deprivation therapy for prostate cancer
    Kincade, MC
    Derweesh, IH
    Malcolm, J
    Lamar, KD
    Patterson, AL
    Kitabchi, AE
    Wake, R
    JOURNAL OF UROLOGY, 2006, 175 (04): : 41 - 41
  • [48] The Effects of Androgen-Deprivation Therapy on MRI Delta Radiomics Features in a Prospective Radiotherapy Treatment Trial for Prostate Cancer
    Stoyanova, R.
    Lopez, C.
    Breto, A. L.
    Xu, I. R.
    Kwon, D.
    Franco, G. C.
    Dal Pra, A.
    Abramowitz, M. C.
    Punnen, S.
    Pollack, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E354 - E354
  • [49] Androgen Deprivation Therapy and the Risk of Death From Prostate Cancer Among Men With Favorable or Unfavorable Intermediate-Risk Disease
    Keane, Florence K.
    Chen, Ming-Hui
    Zhang, Danjie
    Moran, Brian J.
    Braccioforte, Michelle H.
    D'Amico, Anthony V.
    CANCER, 2015, 121 (16) : 2713 - 2719
  • [50] Avoiding Androgen Deprivation Therapy in Men With High-risk Prostate Cancer: The Role of Radical Prostatectomy as Initial Treatment
    Miocinovic, Ranko
    Berglund, Ryan K.
    Stephenson, Andrew J.
    Jones, J. Stephen
    Fergany, Amr
    Kaouk, Jihad
    Klein, Eric A.
    UROLOGY, 2011, 77 (04) : 946 - 950
12345